Next Generation Sequencing Market Research Reports & Industry Analysis
The next generation sequencing (NGS) industry is altering our understanding of genetics and leading to advancements in healthcare, agriculture, and other critical areas. NGS market growth is being driven by decreasing cost, rapid turnaround times, and the rise of high throughput sequencing, with the power to facilitate large-scale population studies, microbiome research, and cancer genomics. MarketResearch.com provides a collection of next generation sequencing industry reports to help you navigate this evolving landscape and gain in-depth insights.
Next Generation Sequencing Market Analysis
- Drawing on extensive primary and secondary research, our reports provide expert market analysis, company profiles, and strategic recommendations.
- We explain how the next generation sequencing market is evolving, and how you can ensure you are at the forefront of the market.
- In addition, our research pinpoints the most lucrative areas of the market, so you can capitalize on them at the right time.
A Research Partner You Can Trust
With more than two decades of experience in the field, MarketResearch.com has long served a range of clients including leading investment banks, management consulting firms, and Fortune 500 multinational corporations. We collect reports from hundreds of leading firms to create a convenient source of insights accessible through a single platform. Each step of the way, our dedicated research specialists are available to offer expert guidance and recommendations.
Next Generation Sequencing Industry Research & Market Reports
-
Cancer/Tumor Profiling Market by Technology (Immunoassay, Next-generation Sequencing (NGS), Insitu Hybridization, Mass, Spectrometry, PCR, Microarray, and Others) by Biomarker Type (Genomic Biomarkers, and Protein Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, and Others), and by Application (Research Application and Clinical Application) – Global Opportunity Analysis and Industry Forecast, 2024–2030
... and by Application (Research Application and Clinical Application) – Global Opportunity Analysis and Industry Forecast, 2024–2030 Cancer/Tumor Profiling Market was valued at USD 11.75 billion in 2023, and is slated to surpass USD 26.57 billion ... Read More
-
Europe Diagnostics Tests Market - Industry Trends and Forecast to 2033
... to reach USD 133,167,940.95 thousand by 2031 from USD 72,092,456.93 thousand in 2023. Market Segmentation Europe Diagnostic Tests Market, By Type (Routine Tests and Specialized Tests), Component (Services and Products), Technology (Immunoassay-Based, PCR-Based, Next Gen ... Read More
-
Global Diagnostics Tests Market - Industry Trends and Forecast to 2031
... expected to reach USD 264,171,700.00 thousand by 2031 from USD 495,851,713.97 thousand in 2023. Market Segmentation Global Diagnostic Tests Market, By Type (Routine Tests and Specialized Tests), Component (Services and Products), Technology (Immunoassay-Based, PCR-Based, Next ... Read More
-
Non Invasive Prenatal Testing (NIPT) Market Forecasts to 2030 – Global Analysis By Product (Disposables, Ultrasound Devices, Assay Kits & Reagents, Polymerase Chain Reaction Instruments, Next-Generation Sequencing Systems, Microarrays and Other Products), Method, Gestation Period, Technology, Application, End User and By Geography
... Technology, Application, End User and By Geography According to Stratistics MRC, the Global Non-Invasive Prenatal Testing (NIPT) Market is accounted for $4.2 billion in 2023 and is expected to reach $9.1 billion by 2030 growing ... Read More
-
mRNA Vaccines in Infectious Diseases Market Overview
... Current Companies and Brief Market Outlook Messenger RNA (mRNA) is a single-stranded ribonucleic acid that is transcribed from a strand of DNA. mRNA carries the coding information for protein synthesis. mRNA vaccines use mRNA that ... Read More
-
Genomic Cancer Testing Market, By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Microarray, Immunohistochemistry, Other genomic testing technologies), By End-User (Hospitals, Diagnostic Laboratories, Academic and Research Institutions, Cancer Centers, Other healthcare providers), By Biomarker Type (Genetic Biomarkers, Protein Biomarkers, Molecular Biomarkers, Epigenetic Biomarkers), By Service Provider (Diagnostic Laboratories, Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations), By Application (Targeted Therapy Selection, Disease Monitoring, Prognostic Testing, Companion Diagno
... Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Microarray, Immunohistochemistry, Other genomic testing technologies), By End-User (Hospitals, Diagnostic Laboratories, Academic and Research ... Read More
-
Next Generation Sequencing (NGS) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
... including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Next Generation Sequencing (NGS) Tests pipeline products with comparative analysis of the products at various ... Read More
-
Protein Sequencing Market, By Technology (Edman Degradation, Mass Spectrometry, Others), By Product (Instruments, Reagents, Kits & Consumables, Software & Services), By Application (Academic Research, Clinical Diagnosis, Biopharmaceuticals, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
... Academic & Research Institutes, Contract Research Organizations), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) Protein sequencing is a crucial technique used in the field of biochemistry and molecular biology ... Read More
-
mRNA: Therapeutics and Global Markets
... and clinical trial analysis of mRNA. The report also portrays the trends and dynamics affecting the market during the study period. The study covers market projections through 2028 and profiles major market players. By geography, ... Read More
-
Protein Sequencing Market - A Global and Regional Analysis - Analysis and Forecast, 2024-2033
... information is essential for understanding protein function, structure, and its role in various biological processes. By comparing protein sequences, researchers can classify proteins into families based on shared ancestry and evolutionary relationships. This provides valuable ... Read More
-
Synthetic Biology Market Forecasts to 2030 – Global Analysis By Product (Oligonucleotide, Enzymes, Cloning Technologies Kits, Synthetic DNA, Chassis Organism, Synthetic cells, Xeno-Nucleic Acids, Synthetic Clones and Other Products), Technology (Site-Directed Mutagenesis, Nanotechnology, Gene Synthesis, Bioinformatics, Measurement and Modelling, Genome Engineering, Sequencing, NGS Technology, Bioprocessing, Cloning, PCR Technology, Microfluidics and Other Technologies), Application, End User and By Geography
... Bioinformatics, Measurement and Modelling, Genome Engineering, Sequencing, NGS Technology, Bioprocessing, Cloning, PCR Technology, Microfluidics and Other Technologies), Application, End User and By Geography According to Stratistics MRC, the Global Synthetic Biology Market is accounted for ... Read More
-
Precision Oncology Market - By Product Type (Diagnostics {Genetic Tests, Biomarker-based Tests}, Therapeutics), Cancer Type (Breast, Lung, Colorectal, Skin, Prostrate, Stomach), End-user (Hospitals, Diagnostic Centers), Global Forecast 2023-2032
... at 10.6% CAGR from 2023 and 2032 propelled by the continuous advancements in genomic research. Recent breakthroughs in understanding the genetic basis of cancers is enabling the precise identification of molecular alterations and driving the ... Read More
-
Advancements in Next-gen Sequencing and Genomic Analysis
... human biology. From Sanger sequencing to next-generation sequencing, technologies and chemistries have improved/advanced to reduce costs and ensure faster timelines. NGS has integrated itself into basic life science research to understand disease biology for drug ... Read More
-
Bioinformatics Market by Solutions & Services (Knowledge Management, Platforms, Sequence Analysis, Services, Data Analysis), Application (Genomics, Metabolomics, Transcriptomics), Industry (Healthcare, Veterinary, Agriculture) - Global Forecast to 2030
... Platforms, Sequence Analysis, Services, Data Analysis), Application (Genomics, Metabolomics, Transcriptomics), Industry (Healthcare, Veterinary, Agriculture)—Global Forecast to 2030 The bioinformatics market is expected to reach $27.98 billion by 2030, at a CAGR of 13.3% from 2023 ... Read More
-
RNA Analysis/ Transcriptomics Global Market Report 2024
... Inc.; Agilent Technologies Inc.; Bio-Rad Laboratories Inc.; GE Healthcare; Illumina Inc. RNA Analysis/ Transcriptomics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need ... Read More
-
Liquid Biopsy Market (4th Edition), 2018-2022 (Historical Trends) and 2023-2035 (Forecasted Estimates): Distribution by Application (Early Cancer Diagnosis, Patient Monitoring, Treatment Selection, Recurrence Monitoring and Others), Target Disease Indication (Bladder Cancer, Breast Cancer, Colorectal Cancer, Gastric Cancer, Lung Cancer, Prostate Cancer and Others), Type of Circulating Biomarker (Cell Free DNA, Cell Free RNA, Circulating Tumor DNA, Extracellular Vesicles and Others Circulating Biomarkers), Type of Sample (Blood / Plasma and Others), End users (Hospitals, Research Institutes and Others), Stage of Development (Launched and Under Development), Type of Product (Assay kits, Devices, Software/ Algorithms and others), Type of Technique (Polymerase Chain Reaction, Next Generation Sequencing and Others), Application Area ( Clinical use, Research use only) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecast
... Gastric Cancer, Lung Cancer, Prostate Cancer and Others), Type of Circulating Biomarker (Cell Free DNA, Cell Free RNA, Circulating Tumor DNA, Extracellular Vesicles and Others Circulating Biomarkers), Type of Sample (Blood / Plasma and Others), ... Read More
-
Single-cell Analysis: Technology Growth Opportunities
... better and develop drugs based on newly uncovered knowledge of various types of tumors. The rich data provided through this method of analysis gives in-depth insight into gene expression and other factors determining a pathological ... Read More
-
Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028
... example, next-generation sequencing (NGS) technologies have become widely used in genetic diseases, and have grown rapidly in oncology, due to the comprehensive insights they can provide at a relatively low cost. While older, PCR continues ... Read More
-
Clinical Oncology Next Generation Sequencing Global Market Report 2024
... By End User: Hospital Laboratories; Clinical Research Organizations; Diagnostic laboratoriesCovering: Thermo Fisher Scientific; Oxford Nanopore Technologies Ltd.; QIAGEN N.V.; Myriad Genetics Inc.; Illumina Inc. Clinical Oncology Next Generation Sequencing Global Market Report 2024 from The ... Read More
-
Pharmacogenomics Global Market Opportunities And Strategies To 2032
... By End User: Hospitals and Clinics; Research Institutions; Academic InstitutesCovering: Illumina Inc.; Eurofins Scientific; Myriad Genetics Inc.; PerkinElmer Inc.; Centogene N.V. Pharmacogenomics Global Market Opportunities And Strategies To 2032 from The Business Research Company provides ... Read More
-
Global Microbial Single-Cell Sequencing Market Growth (Status and Outlook) 2023-2029
... demand in downstream market, the Microbial Single-Cell Sequencing is forecast to a readjusted size of US$ 8122.1 million by 2029 with a CAGR of 17.5% during review period. The research report highlights the growth potential ... Read More
-
Global Microbial Single-Cell Sequencing Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... million in 2022 and is forecast to a readjusted size of USD 7875.4 million by 2029 with a CAGR of 16.2% during review period. Microbial single-cell sequencing is a highly refined sequencing technology used to ... Read More
-
Global Microbial Single-Cell Sequencing Supply, Demand and Key Producers, 2023-2029
... the forecast period (2023-2029). Microbial single-cell sequencing is a highly refined sequencing technology used to study the genome, transcriptome, metabolome and other molecular characteristics of individual microbial cells in the field of microorganisms. Its development ... Read More
-
Immune Repertoire Sequencing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Recent advancements in next-generation sequencing (NGS) technology have paved the way for groundbreaking discoveries in the field of immune repertoire sequencing. This cutting-edge technique, which probes the complementarity-determining regions of B-cell receptors (BCRs) and T-cell ... Read More
-
High End Cellomics Market, By Product Type (Instruments, Reagents and Consumables, and Software & Services), By Application (Drug discovery, Cancer Research, Neuroscience, Stem Cell Research and Regenerative Medicine, Personalized Medicine, and Others), By Technology (Microscopy, Flow Cytometry, Single-cell Genomics, Mass Spectrometry, Next Generation Sequencing, and Others), By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Contract Research Organizations, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Flow Cytometry, Single-cell Genomics, Mass Spectrometry, Next Generation Sequencing, and Others), By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Contract Research Organizations, and Others), By Geography (North America, Latin America, Europe, Asia ... Read More
Research Assistance
